| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| elotuzumab | slam family member 7 | biotech | NA | drugbank , DGIDB | Multiple Myeloma[MeSHID:D009101] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
318.26 | approved | modulator,inhibitor |
| elotuzumab | slam family member 7 slamf7 | NA | Successful target | TTD , DGIDB | Multiple Myeloma[MeSHID:D009101] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
318.26 | approved | inhibitor |
| elotuzumab | slam family member 7 slamf7 | NA | Successful target | TTD , DGIDB | Multiple Myeloma[MeSHID:D009101] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
318.26 | approved | unknown |
| elotuzumab | slam family member 7 | biotech | NA | drugbank , DGIDB | Multiple Myeloma[MeSHID:D009101] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
318.26 | approved | modulator |
| elotuzumab | slam family member 7 | biotech | NA | drugbank , DGIDB | Multiple Myeloma[MeSHID:D009101] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
318.26 | approved | modulator,antibody |
| elotuzumab | slam family member 7 slamf7 | NA | Successful target | TTD , DGIDB | Multiple Myeloma[MeSHID:D009101] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
318.26 | approved | antibody |
| click here to return to the previous page | ||||||||